Title:
PHARMACEUTICAL COMPOSITION USED FOR SELF-REPLICATION AND/OR INDUCED DIFFERENTIATION OF UNDIFFERENTIATED CELLS
Document Type and Number:
Japanese Patent JP2022037144
Kind Code:
A
Abstract:
To provide a pharmaceutical composition that can be used for self-replication and/or induced differentiation of undifferentiated cells.SOLUTION: For example, the composition contains, as an active ingredient, a compound represented by the general formula in the figure or a salt thereof, or a hydrate of them.SELECTED DRAWING: None
More Like This:
| WO/2003/059350 | DEVELOPMENT OF NOVEL REGULATORS OF ANGIOGENESIS |
| JPH10513181 | [Title of Invention] Transdermal preparation |
| WO/1995/005805 | PROCESS FOR CONDITIONING SUBSTANCES |
Inventors:
ANDO HIDEKI
Application Number:
JP2021204801A
Publication Date:
March 08, 2022
Filing Date:
December 17, 2021
Export Citation:
Assignee:
SKY PHARMA CO LTD
International Classes:
A61K31/44; A61K31/4709; A61K31/506; A61K31/519; A61K31/66; A61P1/18; A61P3/10; A61P9/00; A61P17/02; A61P25/00; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P27/06; A61P29/00; A61P35/00
Attorney, Agent or Firm:
Tomoko Tsujita
Daisuke Muramatsu
Daisuke Muramatsu
Previous Patent: Advanced glycation end product (AGE) precursor scavenger
Next Patent: Highly multiplex PCR method and composition
Next Patent: Highly multiplex PCR method and composition